Multiple Sclerosis Clinical Trials
Multiple Sclerosis clinical trials study new therapies, devices, and diagnostic tools for multiple Sclerosis and related neurological symptoms. Corterve gathers actively recruiting Multiple Sclerosis studies from ClinicalTrials.gov so you can filter them by where you live and whether you may qualify. Neurology trials often include cognitive, imaging, or biomarker assessments. This page is informational only and is not medical advice; discuss participation with your neurologist or physician.
Recruiting Multiple Sclerosis studies
- A Study of Orelabrutinib in Patients With Secondary Progressive Multiple SclerosisNCT07299019PHASE3Zenas BioPharma (USA), LLCPhoenix, Arizona
- Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous SystemNCT00794352National Institute of Allergy and Infectious Diseases (NIAID)Bethesda, Maryland
- A Study of Orelabrutinib in Patients With Primary Progressive Multiple SclerosisNCT07067463PHASE3Zenas BioPharma (USA), LLCPheonix, Arizona
- The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot StudyNCT06796504NASetPoint Medical CorporationIrvine, California
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVONCT03816345PHASE1National Cancer Institute (NCI)Birmingham, Alabama
- Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple SclerosisNCT06864936NAUniversity of Maryland, BaltimoreBaltimore, Maryland
- Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to ZeposiaNCT07732907Bristol-Myers SquibbLawrenceville, New Jersey
- A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 TherapyNCT07609719PHASE4Genentech, Inc.Birmingham, Alabama
- Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)NCT03109288PHASE1, PHASE2National Institute of Allergy and Infectious Diseases (NIAID)Bethesda, Maryland
- A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple SclerosisNCT07225504PHASE3Novartis PharmaceuticalsBirmingham, Alabama
- Understanding and Enhancing Human Health and MovementNCT07738978NALouis Stokes VA Medical CenterCleveland, Ohio
- An Open-label Study of AZD0120 in Adults With Multiple SclerosisNCT07224373PHASE1AstraZenecaTucson, Arizona
Multiple Sclerosis trials by state
Multiple Sclerosis trials by metro
Frequently asked questions
- How do I find recruiting Multiple Sclerosis clinical trials?
- Corterve aggregates actively recruiting Multiple Sclerosis studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Multiple Sclerosis clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Multiple Sclerosis clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.